|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/52 | (2006.01) |
| C07D 239/52 | (2013.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 3898595 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19845846.5 |
| Date of filing the European patent application | 2019-12-13 | |
| (97) | Date of publication of the European application | 2021-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/066125 |
| Date | 2019-12-13 |
| (87) | Number | WO 2020/131597 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201862781356 P | 2018-12-18 | US |
| (72) |
CONVERSO, Antonella , US
EL MARROUNI, Abdellatif , US
FORSTER, Ashley , US
FRIE, Jessica, L. , US
HUNTER, David, N. , US
KUDUK, Scott, D. , US
MITCHELL, Helen, J. , US
NANTERMET, Philippe , US
SHA, Deyou , US
SHIPE, William Daniel , US
WANG, Cheng , US
WANG, Deping , US
|
| (73) |
Merck Sharp & Dohme LLC ,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (54) | PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS |
| PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS |